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Introduction
Inflammasomes are cytosolic, multiprotein complexes assem-
bled by members of the NOD-like receptor (NLR) and PYHIN
protein families in response to pathogen-associated molecular
patterns (PAMPs) and danger signals, and serve as activation
platforms for caspase-1. Recently, a new noncanonical inflamma-
some pathway has been described that activates caspase-11, an
understudied pro-inflammatory caspase. Despite new insights into
the signaling events that control caspase-11 activation, a number
of unanswered questions remain.
What Are the Signals That Trigger Noncanonical
Inflammasome Activation?
Activation of the noncanonical inflammasome pathway has
been observed in response to a number of Gram-negative bacteria
(Citrobacter rodentium, Escherichia coli, Vibrio cholerae, Salmonella
typhimurium, and others), but not with Gram-positive bacteria [1–
3]. This distinction indicates that maybe lipopolysaccharide (LPS),
a component of the outer membrane of Gram-negative bacteria,
could be the activator of caspase-11. Nevertheless, although LPS
plays an important part in the activation of the noncanonical
inflammasome [2,3], LPS alone is not sufficient to activate this
pathway (discussed in detail below), indicating that an additional
bacteria-derived signal must exist.
In this regard, it is intriguing that cholera toxin B (CTB)
together with LPS was shown to be another activator of caspase-11
[1]. Although membrane damage could be a signal for caspase-11
activation, it is unlikely since other pore-forming toxins such as
Clostridium difficile toxin B, listeriolysin O, and adenylcyclase (AC)
toxin do not activate the noncanonical pathway [1]. Another
possible activator would be bacterial RNA, which was recently
proposed to trigger IL-1b maturation and cell death during E. coli
or S. typhimurium infections. Interestingly, inflammasome activation
by bacterial RNA required Trif (TIR-domain-containing adaptor
inducing interferon-b) and NLRP3 [4], which are also involved in
noncanonical inflammasome activation [1–3]. However, the
observation that LPS alone is sufficient to induce caspase-11-
dependent septic shock in vivo [1] would argue against a role for
bacterial RNA. Thus, further experiments will be required to
identify the bacterial signals that trigger the noncanonical
inflammasome pathways and to understand the roles of LPS and
bacterial RNA in this process.
How Does Canonical and Noncanonical
Inflammasome Signaling Differ?
Although both caspase-1 and caspase-11 eventually initiate cell
lysis and the release of processed cytokines and danger signals, the
hallmarks of inflammasome signaling [5], their underlying
mechanisms differ significantly (Figure 1A). Caspase-1 activation
by canonical stimuli induces a pro-inflammatory, lytic cell death
called pyroptosis. Although caspase-11 activation also induces lysis of
the host cell, caspase-11-dependent cell death has features that
distinguish it from pyroptosis. Pyroptosis is accompanied by the
release of mature, processed cytokines (IL-1b and IL-18) that are
secreted by a caspase-1-dependent mechanism called unconvention-
al secretion [6]. In contrast to this, caspase-11 lacks the ability to
cleave these cytokines by itself, since macrophages deficient in Nlrp3,
ASC, or Casp1 still activate caspase-11 and initiate cell death but do
not release mature IL-1b or IL-18. This suggests that caspase-11 acts
in conjunction with the NLRP3 inflammasome to promote cytokine
maturation [1]. The exact mechanism of this interaction is
controversial, which in part could be accounted for by the different
assays that have been used to monitor NLRP3 inflammasome
assembly. Microscopic analysis of ASC speck formation suggests that
caspase-11 acts upstream of NLRP3 [2], which is consistent with
observations reported by the Yuan group [7], while biochemical
enrichment of inflammasomes indicates that caspase-11 is down-
stream of NLRP3 [3]. In conclusion, since caspase-11-mediated cell
death lacks associated cytokine maturation, it resembles a pro-
grammed lytic cell death more like necroptosis than pyroptosis.
Another difference between canonical and noncanonical
inflammasomes is in the release of IL-1a and the danger signal
high-mobility group box 1 (HMGB1). The release of IL-1a and
HMGB1 by canonical inflammasomes requires active caspase-1-
mediated secretion [6], while caspase-1 is not required for their
release in response to CTB and E. coli [1], suggesting that lysis is
the release mechanism for these factors following caspase-11
activation (Figure 1A). Whether caspase-11 also initiates novel
caspase-1 effector mechanisms like the release of eicosanoids [8]
and the secretion of growth factors [5] remains to be determined.
Further work will be required to identify and characterize
additional effector mechanisms of caspase-11 in vitro, such as
phagosome-lysosome fusion (discussed separately below) [9], and
to determine how these affect the role of caspase-11 in
pathogenesis in vivo.
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How Is Pro-Caspase-11 Expression Controlled?
Resting macrophages or dendritic cells (DCs) express very low
levels of pro-caspase-11. The pro-caspase-11 promoter contains
NFkB and STAT binding sites, and expression is highly inducible
by LPS, IFN-c and TNFa treatment [10]. Recently, we and others
have linked caspase-11 expression and activation to the signaling
through Toll-like receptor 4 (TLR4) and Trif [2,3]. The induction
of pro-caspase-11 mRNA and protein expression is significantly
delayed in macrophages from TLR42/2 or Trif2/2 mice following
infection with S. typhimurium ([2] and unpublished results).
Signaling via MyD88 is also involved, since MyD88-deficient
macrophages show a slight delay in pro-caspase-11 induction.
Nevertheless, pro-caspase-11 expression was not totally abolished
in MyD882/2/Trif2/2 macrophages, suggesting that additional
pathways contribute to the transcriptional induction of Casp-11
[2]. Similarly, Rathinam et al. show that LPS treatment or EHEC
infections result in lower levels of pro-caspase-11 induction in
Trif2/2 macrophages [3]. Unexpectedly, their results do not show
a contribution of MyD88 to caspase-11 induction, but their study
did not directly compare Trif2/2 to MyD882/2/Trif2/2 macro-
phages [3].
Trif-dependent induction of pro-caspase-11 expression could
occur either by activating NFkB or through IRF3-mediated
production of type-I-interferon (type-I-IFN). Irf3, Ifnar1 (interferon-
a/b receptor), or STAT-1 deficiency delays pro-caspase-11 induction
in S. typhimurium–infected macrophages, suggesting that the type-I-
IFN pathway contributes to pro-caspase-11 expression. However,
pro-caspase-11 expression is not completely abolished in the
absence of type-I-IFN signaling [2]. In contrast, Rathinam et al.
report that Ifnar1 deficiency completely abolishes pro-caspase-11
expression in response to LPS, IFN-b, or EHEC infection [3]. In
addition, they show that IFN-b treatment significantly increases
pro-caspase-11 expression compared to mock-treated macrophag-
es [3], which is consistent with the observation that IFN-b
treatment slightly increases pro-caspase-11 expression in DCs [11].
Conversely, IFN-b treatment of macrophages does not enhance
pro-caspase-11 levels during Salmonella infections [2]. In conclu-
sion, different pathogens or stimuli seem to induce pro-caspase-11
expression via distinct signaling pathways. Since the pathways that
lead to induction of pro-caspase-11 expression are likely important
for the different models of caspase-11 activation (discussed below),
further analysis of caspase-11 induction is required.
What Is the Mechanism of Caspase-11 Activation?
TLR4/Trif-mediated type-I-IFN production is essential for
caspase-11 activity; macrophages deficient in Tlr4, Trif, Irf3, ifnar,
STAT-1, or Irf9 do not initiate cell death and the release of
processed caspase-11 and cytokines in response to noncanonical
inflammasome stimuli [2,3]. However, the mechanism through
which IFN-b controls caspase-11 activation remains controversial,
and two opposing models have been proposed (Figure 1B, C).
One model for caspase-11 activation suggests a receptor/
scaffold-mediated activation mechanism. We observed that
signaling via IFNaR and STAT-1 is crucial for caspase-11 activity
in macrophages infected with S. typhimurium [2], yet this does not
result from a lack of pro-caspase-11 expression, since significant
levels of pro-caspase-11 are present in cells deficient for
components of the type-I-IFN signaling cascade. Consistently,
MyD882/2/Trif2/2 macrophages, which are deficient for type-I-
IFN production, do express pro-caspase-11 when infected with S.
typhimurium, but do not activate caspase-11. Restoring type-I-IFN
signaling by adding exogenous IFN-b rescues this defect in
Salmonella-infected MyD882/2/Trif2/2 macrophages, and this is
independent of pro-caspase-11 induction [2]. Importantly, treat-
ment with exogenous type-I-IFN in the absence of an infection
does not result in caspase-11 activation in primary BMDMs, as
exemplified by a lack of active caspase-11 p30 in the cell
supernatant and absence of cell death [2]. These results indicate
that in primary macrophages type-I-IFN is required for the
expression of an interferon-inducible activator or receptor for
caspase-11 (Figure 1B). They also raise the possibility that a yet-
unknown bacterial signal is required for the activation of caspase-
11.
In contrast to the receptor/scaffold-mediated activation mech-
anism, Rathinam et al. have suggested that pro-caspase-11
expression is both necessary and sufficient to induce pro-caspase-
11 autoactivation (Figure 1C) [3]. This conclusion was based on
the observation that treating macrophages with LPS, IFN-b, and
IFN-c for 16 h simultaneously induced pro-caspase-11 expression
and activated caspase-11, as judged by the appearance of a
processed caspase-11 p30 band in the lysates of these cells.
However, the significance of this processed cytoplasmic caspase-11
is unclear, since the authors did not provide corresponding cell-
death data for this timepoint and did not show the release of the
caspase-11 p30 subunit into the cell supernatant [3]. To support
the model, Rathinam et al. showed that IFN-b and IFN-c
treatment indeed induced cell death, but only at far later
timepoints (40 h posttreatment) and in BMDMs immortalized
with v-myc/v-raf–expressing J2 retrovirus [3]. However, they did
not show if LPS treatment also induces cell death at 40 h in
immortalized cells. It must be noted though that data obtained
with immortalized macrophages have to be interpreted carefully,
since these cells are known to produce replication-proficient
viruses (unpublished observation).
In conclusion, since LPS pretreatment is routinely used to
prestimulate macrophages and was reported not to induce cell
death even as late as 24 h poststimulation [4], it is unlikely that
LPS treatment alone is sufficient to activate caspase-11. Similarly,
IFN-b treatment in the absence of infection does not induce cell
death in primary cells [12].
Another argument brought forward in support of autoactivation
is the observation that expression of pro-caspase-11 in 293T cells
or cell-free systems results in autoprocessing of caspase-11.
Figure 1. Caspase-11 effector functions and models for caspase-11 activation. (A) Caspase-11 effector functions. Active caspase-11
cooperates with components of the NLRP3 inflammasome to induce caspase-1-dependent maturation of pro-IL-1b and pro-IL-18. It remains to be
determined if caspase-11 activates NLRP3 directly or if additional signals are required. Active caspase-11 also induces cell lysis, resulting in the release
of danger signals such as IL-1a and HMGB-1. Finally, during L. pneumophila infections, caspase-11 controls phagosome-lysosome fusion through the
phosphorylation state of cofilin. (B, C) Two distinct models for caspase-11 activation. (B) Receptor/scaffold-mediated activation. Detection of
Gram-negative bacteria by TLR4 results in the activation of NFkB and subsequent expression of pro-IL-1b and pro-caspase-11. Signaling through Trif
and IRF3 induces expression of type-I-IFNs. Type-I-IFN signaling through IFNaR contributes to pro-caspase-11 expression and induces the expression
of an uncharacterized receptor/activator of caspase-11. Activation of caspase-11 by this factor might require an additional undefined signal,
stemming from the bacterial infection. (C) Autoactivation of pro-caspase-11. Detection of Gram-negative bacteria by TLR4 results in the activation of
NFkB and subsequent expression of pro-IL-1b. Signaling through Trif and IRF3 induces expression of type-I-IFNs, which induces pro-caspase-11
expression. Pro-caspase-11 autoactivates, presumably once a concentration threshold is reached.
doi:10.1371/journal.ppat.1003144.g001
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However, the usefulness of these systems for the study of caspase
activation is limited, since even caspase-1 (which is activated in a
receptor-mediated manner) autoactivates in the 293T cell
expression system [13,14]. In addition, pro-caspase-11 expression
has been successfully restored in casp1/casp11-deficient macro-
phages, and autoactivation has not been reported [9,15].
Given the importance of caspase-11 in pathogenesis, a better
understanding of the mechanism of caspase-11 activation is
definitely required. The identification of a specific caspase-11
receptor and/or a bacterial ligand (other than LPS) required for
caspase-11 activity would resolve this issue.
What Is the Role of Caspase-11 in Phagosome
Maturation?
The Nlrc4/Naip5 inflammasome restricts the replication of
intracellular Legionella pneumophila by activating caspase-1 and
caspase-7. Caspase-11 was recently shown to also restrict the
growth of Legionella in macrophages and in the lungs of infected
mice [9]. Since this was also dependent on a functional dot/Icm
system, NLRC4, and flagellin, the authors of that study have
suggested that NLRC4 could activate caspase-11 [9], which is in
contrast to data reported previously [1]. Finally, the authors
showed that caspase-11 might promote the fusion of the L.
pneumophila vacuole with lysosomes by modulating actin polymer-
ization through cofilin (Figure 1A). These results suggest that
caspase-11 has other effector mechanisms besides cell death and
NLRP3/caspase-1-dependent cytokine maturation. However, the
modulation of phagosome-lysosome fusion might be specific for L.
pneumophila infections, since caspase-1, -7, or -11-dependent growth
restriction has so far not been reported for other bacteria
activating the noncanonical inflammasome [2,3].
What Are the Functions of Caspase-11 In Vivo?
The noncanonical inflammasome pathway has been shown to
be activated by a range of different Gram-negative bacteria but
not by Gram-positive bacteria, suggesting that it is a conserved
mechanism for the detection of these pathogens. But it is less
evident how the activation of caspase-11 benefits the host in the
context of an infection. Growth restriction has been shown to
control bacterial number in the lungs of mice infected with L.
pneumophila [9]; however, caspase-11-mediated cell death often
results in detrimental effects for the host. For example, caspase-11-
mediated cell lysis was responsible for the lethal effects of LPS in a
mouse model of sepsis, which occurred independently of NLRP3,
ASC, and caspase-1, thus excluding an involvement of cytokine
production [1,7]. In addition, caspase-11-mediated cell death
increased susceptibility of mice to S. typhimurium infections in the
absence of caspase-1 [2]. This result was surprising, since caspase-
1-induced pyroptosis is important for the clearance of intracellular
bacterial pathogens [16]. Further analysis showed that in the
absence of caspase-1-initiated innate immune defenses, caspase-
11-dependent cell lysis promotes spread and extracellular replica-
tion of Salmonella, a facultative intracellular bacterial pathogen. It is
conceivable that caspase-11 evolved to support caspase-1 by
providing additional means of inducing cell lysis. But since
caspase-11 has lost the ability to promote cytokine maturation,
caspase-11 activation can be exploited by intracellular pathogens
as a silent way to egress from infected host cells and to spread
within the host. Future work will address how caspase-11 supports
innate immune defenses against other Gram-negative bacterial
pathogens or whether caspase-11 has detrimental effects for the
host in other infectious disease models.
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